Terms: = Kidney tumors AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
657 results:
1. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
Pei F; Tao Z; Lu Q; Fang T; Peng S
World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
[TBL] [Abstract] [Full Text] [Related]
2. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
[TBL] [Abstract] [Full Text] [Related]
3. Natural history of bone-only metastasis in renal cell carcinoma.
Tang B; Duan R; Fan Z; Yan X; Li S; Zhou L; Li J; Xu H; Mao L; Lian B; Wang X; Bai X; Wei X; Li C; Cui C; Si L; Chi Z; Guo J; Sheng X
Urol Oncol; 2024 Apr; 42(4):119.e17-119.e22. PubMed ID: 38383241
[TBL] [Abstract] [Full Text] [Related]
4. Gross Hematuria Does not Affect the Selection of Nephrectomy Types for Clinical Stage 1 Clear Cell Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study.
Xing Z; Xu H; Ai K; Deng H; Hong Y; Deng P; Wang J; Xiong W; Li Z; Zhu L; Li Y
Ann Surg Oncol; 2024 May; 31(5):3531-3543. PubMed ID: 38329657
[TBL] [Abstract] [Full Text] [Related]
5. Intraventricular Cerebral Metastases: A Comprehensive Systematic Review.
Scalia G; Silven MP; Costanzo R; Porzio M; Maugeri R; Iacopino DG; Nicoletti GF; Umana GE
Anticancer Res; 2024 Feb; 44(2):453-462. PubMed ID: 38307552
[TBL] [Abstract] [Full Text] [Related]
6. Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.
Fukuda N; Toda K; Suto H; Oki R; Wang X; Urasaki T; Sato Y; Nakano K; Ono M; Tomomatsu J; Mitani H; Takahashi S
Endocr J; 2024 Apr; 71(4):363-371. PubMed ID: 38296547
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.
Matsushita Y; Kojima T; Osawa T; Sazuka T; Hatakeyama S; Goto K; Numakura K; Yamana K; Kandori S; Fujita K; Ueda K; Tanaka H; Tomida R; Kurahashi T; Bando Y; Nishiyama N; Kimura T; Yamashita S; Kitamura H; Miyake H;
Int J Urol; 2024 May; 31(5):526-533. PubMed ID: 38240169
[TBL] [Abstract] [Full Text] [Related]
8. Multidimensional comprehensive and integrated analysis of the potential function of TMEM25 in renal clear cell carcinoma with low expression status.
Xi P; Zhang Z; Liu Y; Nie Y; Gong B; Liu J; Huang H; Liu Z; Sun T; Xie W
Aging (Albany NY); 2024 Jan; 16(1):367-388. PubMed ID: 38189809
[TBL] [Abstract] [Full Text] [Related]
9. Percutaneous ablation of renal tumors: Long-term outcomes.
Del Cura Rodríguez JL; Zabala-Landa R; Korta-Gomez I
Radiologia (Engl Ed); 2023; 65(6):492-501. PubMed ID: 38049248
[TBL] [Abstract] [Full Text] [Related]
10. The results of surgery for renal cell carcinoma metastases of the pancreas.
Riemenschneider KA; Farooqui W; Penninga L; Storkholm JH; Hansen CP
Scand J Gastroenterol; 2024 Mar; 59(3):354-360. PubMed ID: 38042983
[TBL] [Abstract] [Full Text] [Related]
11. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
[TBL] [Abstract] [Full Text] [Related]
12. Influence of preoperative body mass index on prognosis for patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
Chen JC; Huang TH; Wei TC; Huang IS; Fan YH; Lin CC; Lin TP; Chung HJ; Lu SH; Kuo JY; Wu HHH; Chang YH; Lin ATL; Huang WJ; Huang EY
World J Urol; 2023 Dec; 41(12):3575-3583. PubMed ID: 37924334
[TBL] [Abstract] [Full Text] [Related]
13. Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities.
Liu S; Sun H; Yang S; Liang N; Gao Y; Qu S; Chen H
J Endocrinol Invest; 2024 May; 47(5):1119-1128. PubMed ID: 37906371
[TBL] [Abstract] [Full Text] [Related]
14. Histiocytic sarcoma in renal transplant patients: a literature review.
Salehi M; Rehman S; Qutab M; Altheeb R; Prakash R; Jafari HR
J Med Case Rep; 2023 Oct; 17(1):416. PubMed ID: 37784161
[TBL] [Abstract] [Full Text] [Related]
15. Early kinetics of C-reactive protein as prognosticator for survival in a real-world cohort of patients with metastatic renal cell cancer under first-line therapy with immune checkpoint inhibitors.
Schüttke V; Kusiek C; Fuessel S; Thomas C; Buerk BT; Erdmann K
Clin Transl Oncol; 2024 May; 26(5):1117-1128. PubMed ID: 37695463
[TBL] [Abstract] [Full Text] [Related]
16. Deciphering the implications of mitophagy-related signatures in clinical outcomes and microenvironment heterogeneity of clear cell renal cell carcinoma.
Xiang J; Liu W; Liu S; Wang T; Tang H; Yang J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16015-16030. PubMed ID: 37689589
[TBL] [Abstract] [Full Text] [Related]
17. Dose comparison of robustly optimized intensity modulated proton therapy (IMPT) vs IMRT and VMAT photon plans for testicular seminoma.
Rønde HS; Kronborg C; Høyer M; Hansen J; Bak ME; Agergaard SN; Als AB; Agerbæk M; Lauritsen J; Meidahl Petersen P; Dysager L; Kallehauge JF
Acta Oncol; 2023 Oct; 62(10):1222-1229. PubMed ID: 37683054
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of the clinical behavior of unclassified renal cell carcinoma and its imaging findings on computed tomography and magnetic resonance imaging based on World Health Organization (WHO) 2022.
Yamamoto A; Tamada T; Higaki A; Arita Y; Ueno Y; Murakami T; Jinzaki M
Jpn J Radiol; 2024 Jan; 42(1):78-86. PubMed ID: 37596486
[TBL] [Abstract] [Full Text] [Related]
19. Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated ccRCC.
Li L; Bao H; Xu Y; Yang W; Zhang Z; Ma K; Zhang K; Zhou J; Gong Y; Ci W; Gong K
Mol Diagn Ther; 2023 Nov; 27(6):741-752. PubMed ID: 37587253
[TBL] [Abstract] [Full Text] [Related]
20. Renal Medullary Carcinoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis.
Haupt T; Akinyemi O; Raju RA; Wadley AE; Nnorom S; Aponte V; Thelus J; Tonkin JB; Coleman PW; Metwalli AR
J Surg Res; 2023 Dec; 292():1-6. PubMed ID: 37567029
[TBL] [Abstract] [Full Text] [Related]
[Next]
